PCI | SPEED | |||||||
---|---|---|---|---|---|---|---|---|
Baseline (NS) | Assess 5 (NS) | Baseline (NS) | Baseline (NS) | Assess 5 (NS) | Baseline (NS) | |||
Measurements at: | ||||||||
Median | 0.68 | 0.55 | 0.68 | 0.57 | 0.67 | 0.57 | ||
Mean | 0.88 | 0.64 | 0.88 | 0.63 | 0.74 | 0.63 | ||
SD | 0.81 | 0.39 | 0.81 | 0.27 | 0.32 | 0.27 | ||
Compared with: | Assess 5 (NS) | Assess 5 (S) | Assess 5 (S) | Assess 5 (NS) | Assess 5 (S) | Assess 5 (S) | ||
(therapeutic effect) | (orthotic effect) | (combined effect) | (therapeutic effect) | (orthotic effect) | (combined effect) | |||
Median | 0.55 | 0.50 | 0.50 | 0.67 | 0.71 | 0.71 | ||
Mean | 0.64 | 0.57 | 0.57 | 0.74 | 0.79 | 0.79 | ||
SD | 0.39 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | ||
Median change | −0.13 | −0.05 | −0.18 | 0.10 | 0.04 | 0.14 | ||
Change (% ) | −15.24% | −9.35% | −21.9% | 16.40% | 6.87% | 22.52% | ||
Wicoxon signed ranks test p value | 0.003 | 0.003 | 0.001 | 0.001 | 0.002 | <0.001 | ||
95% Confidence Interval | −0.022 to 0.491 | 0.023 to 0.119 | 0.028 to 0.582 | −0.148 to −0.063 | −0.085, −0.020 | −0.213, −0.103 |
Percentage changes are shown and changes significant at the 99% level are shown in bold (n=18) NS=without stimulation; S=with stimulation.